Penbrook Management
BMY icon

Penbrook Management’s Bristol-Myers Squibb BMY Stock Holding History

Penbrook Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$413K Hold
6,615
– – 0.24% 72
2026
Q2 		$381K Buy
6,615
+365
+6% +$21K 0.24% 75
2026
Q1 		$379K Hold
6,250
– – 0.29% 67
2025
Q4 		$337K Buy
+6,250
New +$301K 0.23% 68

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Penbrook Management's BMY Position: Q3 2026 in Review

Penbrook Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 6,615 shares worth $413K. The position accounts for 0.24% of the portfolio, ranked #72.

Penbrook Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 682 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Penbrook Management held 6,615 shares of Bristol-Myers Squibb worth $413K as of Q3 2026.
  • Penbrook Management left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.24% of Penbrook Management's portfolio in Q3 2026, its #72 holding.
  • Penbrook Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 682 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Penbrook Management's 13F filing for Q3 2026, filed 16 Oct 2026.